Literature DB >> 8397793

Botulinum type A neurotoxin digested with pepsin yields 132, 97, 72, 45, 42, and 18 kD fragments.

J A Gimenez1, B R DasGupta.   

Abstract

Botulinum neurotoxin (NT) serotype A is a dichain protein made of a light and a heavy chain linked by at least one interchain disulfide; based on SDS-polyacrylamide gel electrophoresis their molecular masses appear as 147, 52, and 93 kD, respectively. Digestion of the NT with pepsin under controlled pH (4.3 and 6.0), time (1 and 24 hr), and temperature (25 and 30 degrees C) produced 132, 97, 42, and 18 kD fragments. The three larger fragments were isolated by ion-exchange chromatography. The 132 and 97 kD fragments are composed of 52 kD light chain and 72 and 45 kD fragments of the heavy chain, respectively. The sequences of amino terminal residues of these fragments were determined to identify the pepsin cleavage sites in the NT, which based on nucleotide sequence has 1295 amino acid residues (Binz et al., J. Biol. Chem. 265, 9153, 1990). The 42 kD fragment, beginning with residue 866, is the C-terminal half of the heavy chain. The 18 kD fragment, of which the first 72 residues were identified beginning with residue 1147, represents the C-terminal segment of the heavy chain. The 132 kD fragment (residue 1 to approximately 1146) is thus a truncated version of the NT without its 18 kD C-terminal segment. The 97 kD fragment (residue 1 to approximately 865) is also a truncated NT with its 42 kD C-terminal segment excised. These peptic fragments contain one or two of the three functional domains of the NT (binds receptors, forms channels, and intracellularly inhibits exocytosis of the neurotransmitter) that can be used for structure-function studies of the NT. This report also demonstrates for the first time that of the six Cys residues 453, 790, 966, 1059, 1234, and 1279 located in the heavy chain the later four do not form interchain disulfide links with the light chain; however, Cys 1234 and 1279 contained within the 18 kD fragment form intrachain disulfide. The electrophoretic behaviors of type A NT and its fragments in native gels and their comparison with botulinum NT serotypes B and E as well as tetanus NT suggest that each NT forms dimers or other aggregates and the aggregation does not occur when the 42 kD C-terminal half of the heavy chain is excised. Thus, the C-terminal half of the heavy chain appears important in the self-association to form dimers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397793     DOI: 10.1007/bf01028197

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  39 in total

1.  Botulinum neurotoxin type E fragmented with endoproteinase Lys-C reveals the site trypsin nicks and homology with tetanus neurotoxin.

Authors:  J A Giménez; B R DasGupta
Journal:  Biochimie       Date:  1990-04       Impact factor: 4.079

2.  The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene.

Authors:  D E Thompson; J K Brehm; J D Oultram; T J Swinfield; C C Shone; T Atkinson; J Melling; N P Minton
Journal:  Eur J Biochem       Date:  1990-04-20

3.  Changes in the molecular topography of the light and heavy chains of type A botulinum neurotoxin following their separation.

Authors:  B R Singh; B R DasGupta
Journal:  Biophys Chem       Date:  1989-11       Impact factor: 2.352

4.  Isolation and characterization of Clostridium botulinum type B toxin.

Authors:  W H Beers; E Reich
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Nature of intracellular type A botulinum neurotoxin.

Authors:  E P Krysinski; H Sugiyama
Journal:  Appl Environ Microbiol       Date:  1981-03       Impact factor: 4.792

7.  Light chain of botulinum neurotoxin is active in mammalian motor nerve terminals when delivered via liposomes.

Authors:  A de Paiva; J O Dolly
Journal:  FEBS Lett       Date:  1990-12-17       Impact factor: 4.124

8.  Response of the chick ciliary ganglion-iris neuromuscular preparation to botulinum neurotoxin.

Authors:  R Lomneth; J B Suszkiw; B R DasGupta
Journal:  Neurosci Lett       Date:  1990-05-31       Impact factor: 3.046

9.  Pepsin fragmentation of botulinum type E neurotoxin: isolation and characterization of 112, 48, 46, and 16 kD fragments.

Authors:  J A Giménez; B R DasGupta
Journal:  J Protein Chem       Date:  1992-06

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  5 in total

1.  Multiplex PCR for detection of botulinum neurotoxin-producing clostridia in clinical, food, and environmental samples.

Authors:  Dario De Medici; Fabrizio Anniballi; Gary M Wyatt; Miia Lindström; Ute Messelhäusser; Clare F Aldus; Elisabetta Delibato; Hannu Korkeala; Michael W Peck; Lucia Fenicia
Journal:  Appl Environ Microbiol       Date:  2009-08-14       Impact factor: 4.792

2.  The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.

Authors:  B Vijayalakshmi Ayyar; K Roger Aoki; M Zouhair Atassi
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

Review 3.  Glycosphingolipids-sweets for botulinum neurotoxin.

Authors:  Brian C Yowler; Cara-Lynne Schengrund
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 4.  Septins: Regulators of Protein Stability.

Authors:  Olga Vagin; David O Beenhouwer
Journal:  Front Cell Dev Biol       Date:  2016-12-20

Review 5.  Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.

Authors:  Jonathan R Davies; Sai Man Liu; K Ravi Acharya
Journal:  Toxins (Basel)       Date:  2018-10-20       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.